PILOT STUDY OF INTRAVITREAL INJECTION OF DICLOFENAC FOR TREATMENT OF MACULAR EDEMA OF VARIOUS ETIOLOGIES

201066 citationsJournal Article

Authors

Masoud Soheilian · Shahid Beheshti University

Saeed Karimi · Shahid Beheshti University

Alireza Ramezani · Basir Eye Health Research Center

Gholam A. Peyman · University of Arizona

Abstract

Up to 8 weeks, intravitreal diclofenac treatment of eyes with macular edema of various etiologies yielded prominent improvement in visual acuity but was not associated with a significant decrease in central macular thickness. No toxic effect of intravitreal diclofenac was observed.

Topics & Keywords

Retinal Diseases and Treatments Retinal and Optic Conditions Ocular Diseases and Behçet’s Syndrome

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Retina

Volume 30, Issue 3, pp. 509-515

DOI: 10.1097/iae.0b013e3181bdfa43

Field-Weighted Citation Impact: 6.66